Programs Brought to Clinic
1 +
Clinical Batches Manufactured
1 +
Service Specializations
1 +

AAV

Gene Therapy Expertise NEW

A Trusted Partner in Drug Development Proven Solutions for Drug Development Success

At DES Pharma (Dynamic Engineering Solutions), we specialize in product and analytical development. Our services encompass everything from pre-clinical drug development to clinical manufacturing and product commercialization.

FAST, PRECISE & COMPLIANTPersonalized Support for
Pharma Programs

We bring the expertise and focus needed to move your
product forward with speed and confidence.

Program & Process Development

Phase-appropriate process development that ensures product quality, data-driven improvements, and efficient progress from pre-clinical through commercial launch.

AAV Expertise

Including AAV capsid development, producer cell line optimization, and viral vector manufacturing scale-up

Quality Control & Analytics

We develop robust analytical methods and leverage scientific expertise to ensure product quality, safety, and efficacy throughout every stage of development.

Gene Therapy Analytics

Specialized AAV characterization methods including empty/full capsid ratio, vector genome titer, and residual DNA testing

Supply Chain & Procurement

Customized, end-to-end supply chain strategies to ensure reliable, cost-effective drug product supply from development through commercialization.

Viral Vector Sourcing

Viral vector-specific raw material sourcing including plasmids, helper virus systems, and chromatography resins

Quality Assurance

Comprehensive QA services ensuring compliance and product integrity, including deviation and CAPA management, batch release, and audit support.

Gene Therapy Compliance

Gene therapy-specific compliance including adventitious agent testing and vector shedding protocols

Gene Therapy & Viral Vector Expertise Gene Therapy & Viral Vector Expertise

At DES Pharma, we bring deep expertise in AAV gene therapy development across all serotypes and manufacturing platforms. Our team has hands-on experience with AAV2, AAV5, AAV8, AAV9, and novel capsid variants, supporting clients through critical development milestones from construct design through commercial manufacturing.

We understand the unique challenges of AAV development: optimizing empty/full capsid ratios, scaling from adherent to suspension cell culture, selecting appropriate purification strategies, and navigating complex regulatory requirements for gene therapies. Whether you’re developing producer cell lines, transitioning from triple-plasmid-to-baculovirus platform support, or preparing for your first IND submission, our consultants provide the technical depth and regulatory insight to accelerate your program.

Our AAV-specific services span the entire development lifecycle, including viral vector characterization, potency assay development, CDMO tech transfer, and BLA preparation support. We help gene therapy companies avoid common pitfalls, reduce manufacturing variability, and build robust processes that meet FDA and EMA expectations.

Serotypes Supported

Capsid Optimization & Producer Cell Lines

Empty/full ratio optimization, adherent-to-suspension transitions, and triple plasmid-to-baculovirus platform support

Potency Assay Development

Vector genome titer, transduction efficiency, and residual DNA testing—IND through BLA

CDMO Tech Transfer & Scale-Up

Vendor selection, tech transfer packages, and manufacturing variability reduction

Regulatory Strategy (IND / BLA)

FDA and EMA-aligned CMC filings, adventitious agent testing, vector shedding protocols

Driving Results & Impact Real Results at Every Stage

End-to-End Development Support

Expertise across the entire drug product lifecycle that helps you meet your milestones.

Efficient, Results-Oriented Approach

Focused on essential experiments and processes to accelerate development.

Robust Quality & Compliance

Ensuring product safety, integrity, and regulatory adherence at every stage.

50+
Programs Brought to Clinic

200+

Clinical Batches Manufactured

“Built on Science, Focused on Safety”

Reliable product quality begins with a strategic, system-driven development process. Our team applies a disciplined program design that minimizes risk, streamlines operations, and safeguards patient safety.
 

Built on Science Consistent Quality, Safer Outcomes

Reliable product quality begins with a strategic, system-driven development process. Our team at DES Pharma applies a disciplined program design that minimizes risk, streamlines operations, and safeguards patient safety.

By embedding quality and compliance at the core of every stage, we deliver results you can trust.

Minimize Risk

Strategic program design eliminates downstream failures

Streamline Operations

Efficient processes from IND through commercialization

Safeguard Patient Safety

Regulatory-aligned quality systems that protect patients

Get Started Advance Your Drug Program with Confidence

Start building reliable, high-quality drug development programs today.